Abstract
Abstract:Pneumocystis pneumonia is an increasingly recognized threat in non-HIV immunosuppressed patients and is associated with worse outcomes compared to HIV-infected patients. The preferred first line treatment is trimethoprim-sulfamethoxazole; however, second line treatments for those intolerant of this regimen have been primarily studied in patients with acquired immunodeficiency syndrome (AIDS). We report a case of Pneumocystis pneumonia in a 75-year-old man with chronic lymphocytic leukemia (CLL) and a history of sulfa allergy successfully treated with clindamycin-primaquine.
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view purchase options.
Create a free account, then purchase this article to download or access it online for 24 hours.
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
References
References1. Monnet X, Vidal-Petiot E, Osman D, et al. Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection. Crit Care 2008;12:R28.MonnetX]]Vidal-PetiotE]]OsmanD&etal;Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection.Crit Care200812R282. Smego RA Jr, Nagar S, Maloba B, et al. A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia. Arch Intern Med 2001;161:1529–1533.SmegoRAJr]]NagarS]]MalobaB&etal;A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia.Arch Intern Med20011611529-15333. Toma E, Thorne A, Singer J, et al. Clindamycin with primaquine vs. trimethoprim-sulfamethoxazole therapy for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS: a multicenter, double-blind, randomized trial (CTN 004). Clin Infect Dis 1998;27:524–530.TomaE]]ThorneA]]SingerJ&etal;Clindamycin with primaquine vs. trimethoprim-sulfamethoxazole therapy for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS: a multicenter, double-blind, randomized trial (CTN 004).Clin Infect Dis199827524-5304. Zahar JR, Robin M, Azoulay E, et al. Pneumocystis carinii pneumonia in critically ill patients with malignancy: a descriptive study. Clin Infect Dis 2002;35:929–934.ZaharJR]]RobinM]]AzoulayE&etal;Pneumocystis carinii pneumonia in critically ill patients with malignancy: a descriptive study.Clin Infect Dis200235929-9345. Sepkowitz KA. Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome. Clin Infect Dis 2002;34:1098–1107.SepkowitzKAOpportunistic infections in patients with and patients without acquired immunodeficiency syndrome.Clin Infect Dis2002341098-11076. Kolstad A, Holte H, Fosså A, et al. Pneumocystis jiroveci pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen. Haematologica 2007;92:139–140.KolstadA]]HolteH]]FossåA&etal;Pneumocystis jiroveci pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen.Haematologica200792139-1407. Overgaard UM, Helweg-larsen J. Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: a retrospective study 2002–2004. Scan J Infect Dis 2007;39:589–595.OvergaardUM]]Helweg-larsenJPneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: a retrospective study 2002–2004.Scan J Infect Dis200739589-5958. Kovacs JA, Hiemenz JW, Macher AM, et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 1984;100:663–671.KovacsJA]]HiemenzJW]]MacherAM&etal;Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies.Ann Intern Med1984100663-6719. Mansharamani NG, Garland R, Delaney D, et al. Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states. Chest 2000;118:704–711.MansharamaniNG]]GarlandR]]DelaneyD&etal;Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states.Chest2000118704-71110. Pagano L, Fianchi L, Mele L, et al. Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years’ experience of infection in GIMEMA centres. Br J Haematol 2002;117:379–386.PaganoL]]FianchiL]]MeleL&etal;Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years’ experience of infection in GIMEMA centres.Br J Haematol2002117379-38611. Thomas CF Jr, Limper AH. Pneumocystis Pneumonia. N Engl J Med 2004;350:2487–2498.ThomasCFJr]]LimperAHPneumocystis Pneumonia.N Engl J Med20043502487-249812. Benfield T, Atzori C, Miller RF, et al. Second-line salvage treatment of AIDS-associated Pneumocystis jirovecii pneumonia: a case series and systematic review. J Acquir Immune Defic Syndr 2008;48:63–67.BenfieldT]]AtzoriC]]MillerRF&etal;Second-line salvage treatment of AIDS-associated Pneumocystis jirovecii pneumonia: a case series and systematic review.J Acquir Immune Defic Syndr20084863-6713. O’Brien JG, Dong BJ, Coleman RL, et al. A 5-year retrospective review of adverse drug reactions and their risk factors in human immunodeficiency virus-infected patients who were receiving intravenous pentamidine therapy for Pneumocystis carinii pneumonia. Clin Infect Dis 1997;24:854–859.O’BrienJG]]DongBJ]]ColemanRL&etal;A 5-year retrospective review of adverse drug reactions and their risk factors in human immunodeficiency virus-infected patients who were receiving intravenous pentamidine therapy for Pneumocystis carinii pneumonia.Clin Infect Dis199724854-859
